Standard Glass Lining Technology Limited Delivers Strong Q1 FY26 Performance

Entered into a long-term agency agreement with M/s. BioCon Solutions Pte Ltd, Singapore

• Enables export of SGLTL’s manufactured products to BioCon’s customers
• Covers key Southeast Asian territories -Singapore, Indonesia, Malaysia, and Thailand
• Strengthens our international footprint and opens access to new industrial customers in high-growth markets
• Combines SGLTL’s manufacturing excellence with BioCon’s market reach and distribution network

Incorporated Standard Engineering Inc. in the USA as a wholly owned subsidiary 

• Based in the State of South Carolina, USA, a growing hub for industrial manufacturing
• Will cater to Industrial Products and Process Equipment segment
• Marks a significant step in the Company’s international growth strategy and customer proximity
• Expected to enhance supply chain responsiveness and unlock new customer opportunities in the North American market

Key Highlights for Q1 FY26 Financial Results

• Total Income stood at ₹178 crore, registering a 23.6% YoY growth
• EBITDA came in at ₹35 crore, up 31.9% YoY, with an EBITDA margin of 19.5%
• Profit Before Tax (PBT) is ₹28 crore, reflecting a 39.6% YoY increase
• Profit After Tax (PAT) is at ₹21 crore, up 37.6% YoY, with a PAT margin of 11.9%

Management Commentary 

Mr. Nageswara Rao Kandula, Managing Director, said: “We are pleased with our continued healthy performance this quarter, which reflects our unwavering commitment to our customers, investors and all stakeholders. Through improved execution, we have delivered good margins while also expanding our exports and establishing our global footprint. Our focus on innovation has enhanced our reputation with customers, and our new offerings are gaining acceptance and appreciation. We remain confident that our efforts in technology development, product diversification, and international market expansion will open new avenues for sustainable, long-term growth.

We also believe that the rapid growth of the CDMO business in India presents a significant opportunity for the Indian engineering industry. As global pharma and chemical companies increasingly turn to India for high-quality, cost-effective manufacturing solutions, we are well-positioned to benefit from this trend—thanks to our strong customer relationships, proven execution capabilities, and engineering excellence

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.